Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2′-deoxyuridine cream
- 1 June 1985
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 5 (3) , 169-177
- https://doi.org/10.1016/0166-3542(85)90049-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Early, patient-initiated treatment of herpes labialis with topical 10% acyclovirAntimicrobial Agents and Chemotherapy, 1984
- Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infectionAntimicrobial Agents and Chemotherapy, 1984
- Comparative Efficacy of Antiberpes Drugs Against Various Strains of Varicella-Zoster VirusThe Journal of Infectious Diseases, 1983
- Chemotherapeutic Efficacy of E-5-(2-Bromovinyl)-2'-Deoxyuridine for Orofacial Infection with Herpes Simplex Virus Type 1 in MiceThe Journal of Infectious Diseases, 1982
- Efficiency and selectivity of (E)-5-(2-bromovinyl)-2′-deoxyuridine and some other 5-substituted 2′-deoxypyrimidine nucleosides as anti-herpes agentsAntiviral Research, 1982
- Therapeutic Effects of Foscarnet Sodium and Acyclovir on Cutaneous Infections Due to Herpes Simplex Virus Type 1 in Guinea PigsThe Journal of Infectious Diseases, 1982
- Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex VirusThe Journal of Infectious Diseases, 1980
- Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude miceAntimicrobial Agents and Chemotherapy, 1979
- Guinea Pig Model for Cutaneous Herpes Simplex Virus InfectionJournal of Investigative Dermatology, 1974
- Permeability of the skinPhysiological Reviews, 1971